Abstract 4865: BI 907828: A highly potent MDM2 inhibitor with low human dose estimation, designed for high-dose intermittent schedules in the clinic
暂无分享,去创建一个
C. Haslinger | N. Kraut | D. Rudolph | P. Garin‐Chesa | J. Moll | J. Quant | Ulrike Weyer-Czernilofsky | A. Gollner | D. McConnell | Joerg Rinnenthal | Sophia M. Blake | Andreas Wernitznig